X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (747) 747
Publication (112) 112
Paper (29) 29
Report (24) 24
Newspaper Article (4) 4
Book Chapter (3) 3
Data Set (2) 2
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (285) 285
humans (265) 265
female (175) 175
male (144) 144
middle aged (116) 116
adult (110) 110
physics (97) 97
physics, particles & fields (88) 88
hadron-hadron scattering (83) 83
aged (82) 82
analysis (70) 70
research (67) 67
animals (66) 66
elementary particles, quantum field theory (64) 64
quantum field theories, string theory (64) 64
cms (58) 58
cern lhc coll (55) 55
classical and quantum gravitation, relativity theory (54) 54
quantum physics (54) 54
article (53) 53
cancer (53) 53
experiment (52) 52
oncology (52) 52
medicine (49) 49
experimental results (47) 47
p p: scattering (46) 46
health aspects (44) 44
high energy physics - experiment (43) 43
breast cancer (41) 41
abridged index medicus (40) 40
b physics (40) 40
high energy physics (40) 40
research article (39) 39
risk factors (39) 39
care and treatment (36) 36
medicine & public health (35) 35
mutation (35) 35
adolescent (34) 34
astronomy & astrophysics (34) 34
physiological aspects (34) 34
studies (33) 33
to be checked by faculty (33) 33
tool (33) 33
decay (31) 31
flavor physics (31) 31
patients (31) 31
medical research (30) 30
medicine, general & internal (30) 30
treatment outcome (30) 30
p p: colliding beams (29) 29
prognosis (29) 29
mice (28) 28
multidisciplinary sciences (28) 28
particle physics (28) 28
aged, 80 and over (27) 27
diabetes (27) 27
genetic aspects (27) 27
luminosity (27) 27
young adult (27) 27
branching fraction (26) 26
survival (26) 26
usage (26) 26
13000 gev-cms (25) 25
gene expression (25) 25
physics - high energy physics - experiment (25) 25
proteins (25) 25
cell biology (24) 24
mortality (24) 24
risk (24) 24
disease (23) 23
genes (23) 23
life sciences (23) 23
physics of elementary particles and fields (23) 23
prevalence (23) 23
science (23) 23
surgery (23) 23
diagnosis (22) 22
immunology (22) 22
infectious diseases (22) 22
phenomenology (22) 22
physics, nuclear (22) 22
biology (21) 21
drug therapy (21) 21
epidemiology (21) 21
expression (21) 21
large hadron collider (21) 21
medical and health sciences (21) 21
medicin och hälsovetenskap (21) 21
neurosciences (21) 21
prospective studies (21) 21
collisions (20) 20
genetics (20) 20
public, environmental & occupational health (20) 20
qcd (20) 20
tumors (20) 20
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (19) 19
age (19) 19
association (19) 19
confidence intervals (19) 19
prevention (19) 19
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Goss, Paul E, Prof and Lee, Brittany L, MD and Badovinac-Crnjevic, Tanja, MD and Strasser-Weippl, Kathrin, MD and Chavarri-Guerra, Yanin, MD and Louis, Jessica St, BA and Villarreal-Garza, Cynthia, MD and Unger-Saldaña, Karla, PhD and Ferreyra, Mayra, MD and Debiasi, Márcio, MD and Liedke, Pedro ER, MD and Touya, Diego, MD and Werutsky, Gustavo, MD and Higgins, Michaela, MD and Fan, Lei, MD and Vasconcelos, Claudia, MD and Cazap, Eduardo, MD and Vallejos, Carlos, MD and Mohar, Alejandro, MD and Knaul, Felicia, PhD and Arreola, Hector, MD and Batura, Rekha, MD and Luciani, Silvana, MD and Sullivan, Richard, MD and Finkelstein, Dianne, PhD and Simon, Sergio, MD and Barrios, Carlos, MD and Kightlinger, Rebecca, DO and Gelrud, Andres, MD and Bychkovsky, Vladimir, MSc and Lopes, Gilberto, MD and Stefani, Stephen, Prof and Blaya, Marcelo, MD and Souza, Fabiano Hahn, MD and Santos, Franklin Santana, MD and Kaemmerer, Alberto, MD and de Azambuja, Evandro, MD and Zorilla, Andres Felipe Cardona, MD and Murillo, Raul, MD and Jeronimo, Jose, MD and Tsu, Vivien, PhD and Carvalho, Andre, MD and Gil, Carlos Ferreira, MD and Sternberg, Cinthya, PhD and Dueñas-Gonzalez, Alfonso, MD and Sgroi, Dennis, MD and Cuello, Mauricio, MD and Fresco, Rodrigo, MD and Reis, Rui Manuel, PhD and Masera, Guiseppe, MD and Gabús, Raúl, MD and Ribeiro, Raul, MD and Knust, Renata, MD and Ismael, Gustavo, MD and Rosenblatt, Eduardo, MD and Roth, Berta, MD and Villa, Luisa, MD and Solares, Argelia Lara, MD and Leon, Marta Ximena, MD and Torres-Vigil, Isabel, DrPH and Covarrubias-Gomez, Alfredo, MD and Hernández, Andrés, MD and Bertolino, Mariela, MD and Schwartsmann, Gilberto, MD and Santillana, Sergio, MD and Esteva, Francisco, MD and Fein, Luis, MD and Mano, Max, MD and Gomez, Henry, MD and Hurlbert, Marc, PhD and Durstine, Alessandra, MBA and Azenha, Gustavo, PhD
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 5, pp. 391 - 436
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9816, pp. 633 - 640
Summary Background The anti-HER2 monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib have complementary mechanisms of action and... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | APOPTOSIS | WOMEN | MEDICINE, GENERAL & INTERNAL | GW572016 | SAFETY | ERBB2 | INHIBITOR | COMBINATION | PLUS | Breast Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Diarrhea - chemically induced | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Liver - drug effects | Adult | Female | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Lapatinib | Biomarkers, Tumor - antagonists & inhibitors | Paclitaxel - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Liver - metabolism | Paclitaxel - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Quinazolines - adverse effects | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Drug therapy | Breast cancer | Genetic aspects | Ultrasonic imaging | Surgery | Diarrhea | Cytotoxicity | Ligands | Cancer therapies | Tumors | Medical research | Mammography | Kinases | pathology | Liver | methods | Antibodies | Oral | Quinazolines | Breast Neoplasms | Tumor Markers | administration & dosage | Paclitaxel | Neoadjuvant Therapy | Adjuvant | Monoclonal | chemistry | Administration | drug therapy | chemically induced | Intravenous | Infusions | Humanized | Antineoplastic Combined Chemotherapy Protocols | drug effects | Biological | analysis | Kirurgi | antagonists & inhibitors | Chemotherapy | Receptor | adverse effects | metabolism | Cancer and Oncology | therapeutic use | Cancer och onkologi | erbB-2
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 60, Issue 20, pp. 2103 - 2114
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9852, pp. 1482 - 1490
Journal Article
Annals of Diagnostic Pathology, ISSN 1092-9134, 2012, Volume 16, Issue 1, pp. 29 - 37
Journal Article